Search results

Information and benefits about shared decision making. Includes links to patient decision aids.

Home What NICE does Life sciences: how to get your product to market NICE Advice service {"@context":"http://schema.org","@type":"BreadcrumbList"

International collaboration with NICE

NICE Advice - a fee-based advisory service for pharmaceutical and healthtech companies seeking to enter the NHS market,

Science policy projects with NICE.

Technology appraisal guidance makes recommendations on the use of new and existing medicines and other treatments within the NHS.

Our projects and partnerships help us anticipate and adapt to policy developments, including changes in health and social care delivery.

NICE Advice works closely with our system partners and industry to drive innovation into the hands of health and care professionals, to enable best practice.

People have the right to be able to make informed decisions about their care. Our guidance should be taken into account when making decisions with them.

The NICE commercial liaison team aim to reduce the workload for the NHS and frontline staff by making commercial agreements more straightforward.

Before 2022, we used different processes for assessing technologies. You can view the previous process and methods guides below.

How providers and commissioners can use quality standards to improve the quality of care

We assess the efficacy and safety of interventional procedures used for treatment or diagnosis to determine whether they work well enough and are safe enough for use in the NHS.

Learn about the NICE Technology Appraisal and Highly Specialised Technologies appeals process, including how decisions are made, the criteria for appeals, and the role of the appeal panel in ensuring fair and transparent evaluations of health technologies.

We assess the value of digital health technologies that offer the greatest potential to improve health and wellbeing.